COCRYSTAL INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Cocrystal Pharma, Inc. To Contact The Firm
NEW YORK, Sept. 21, 2018 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Cocrystal Pharma, Inc. ("Cocrystal" or the "Company") (NASDAQ:COCP) f/k/a BioZone Pharmaceuticals, Inc. ("BioZone").
If you invested in Cocrystal or BioZone stock or options and would like to discuss your legal rights, click here: www.faruqilaw.com/COCP. There is no cost or obligation to you.
You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com.
CONTACT:
FARUQI & FARUQI, LLP
685 Third Avenue, 26th Floor
New York, NY 10017
Attn: Richard Gonnello, Esq.
rgonnello@faruqilaw.com
Telephone: (877) 247-4292 or (212) 983-9330
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
View original content to download multimedia:http://www.prnewswire.com/news-releases/cocrystal-investor-alert-faruqi--faruqi-llp-encourages-investors-who-suffered-losses-exceeding-50-000-investing-in-cocrystal-pharma-inc-to-contact-the-firm-300716971.html
SOURCE Faruqi & Faruqi, LLP
